Changes in brain regions associated with food-intake regulation, body mass and metabolic profiles during acute antipsychotic treatment in first-episode schizophrenia.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Psychiatry Research

• Publication date

  2015-08-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.pscychresns.2015.06.014PMID 26184461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The University of Birmingham ( Live System ) Are There Progressive Brain Changes in Schizophrenia ? A Meta-Analysis of Structural Magnetic Resonance Imaging Studies

  2016cited by this paper
• White Matter Changes Associated with Antipsychotic Treatment in First-Episode Psychosis

  2014cited by this paper
• Effects of eight weeks of atypical antipsychotic treatment on middle frontal thickness in drug-naïve first-episode psychosis patients.

  2013cited by this paper
• Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects.

  2013cited by this paper
• Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies

  2013cited by this paper
• Relationships between gray matter, body mass index, and waist circumference in healthy adults

  2013cited by this paper
• Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.

  2013influential reference
• Association of Obesity-Mediated Insulin Resistance and Hypothalamic Volumes: Possible Sex Differences

  2013cited by this paper
• Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro[S]

  2013cited by this paper
• The Role of Hypothalamic H1 Receptor Antagonism in Antipsychotic-Induced Weight Gain

  2013cited by this paper
• Frontal cortical thinning and subcortical volume reductions in early adulthood obesity.

  2013influential reference
• The Myth of Schizophrenia as a Progressive Brain Disease

  2012cited by this paper
• Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment

  2012cited by this paper
• Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.

  2012cited by this paper
• Metabolic actions of hypothalamic SIRT1.

  2012cited by this paper
• Within-subject template estimation for unbiased longitudinal image analysis

  2012cited by this paper
• The Use of Functional MRI to Study Appetite Control in the CNS

  2012cited by this paper
• Late-life obesity is associated with smaller global and regional gray matter volumes: a voxel-based morphometric study

  2012cited by this paper
• Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment

  2011influential reference
• Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis.

  2011cited by this paper
• Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia.

  2011cited by this paper
• Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

  2011cited by this paper
• In vivo evidence of global and focal brain alterations in anorexia nervosa.

  2011cited by this paper
• Minireview: Inflammation and obesity pathogenesis: the hypothalamus heats up.

  2010cited by this paper
• Hypothalamic inflammation and obesity.

  2010cited by this paper
• Highly accurate inverse consistent registration: A robust approach

  2010cited by this paper
• Structural brain differences and cognitive functioning related to body mass index in older females

  2009cited by this paper
• Weight gain in antipsychotic-naive patients: a review and meta-analysis

  2009influential reference
• Adipose tissue: A motor for the inflammation associated with obesity

  2009cited by this paper
• Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia.

  2009cited by this paper
• The brain, appetite, and obesity

  2008cited by this paper
• Relationship Between Body Mass Index and Gray Matter Volume in 1,428 Healthy Individuals

  2008cited by this paper
• Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.

  2008cited by this paper
• Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.

  2007cited by this paper
• Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study.

  2006cited by this paper
• Antipsychotic drug effects on brain morphology in first-episode psychosis.

  2005cited by this paper
• Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

  2005cited by this paper
• Volume Changes in Gray Matter in First-Episode Neuroleptic-Naive Schizophrenic Patients Treated With Risperidone

  2005cited by this paper
• Weight gain as a prognostic indicator of therapeutic improvement during acute treatment of schizophrenia with placebo or active antipsychotic

  2005cited by this paper
• Longitudinal study of brain morphology in first episode schizophrenia.

  2001cited by this paper
• Cortical surface-based analysis. I. Segmentation and surface reconstruction.

  1999cited by this paper
• Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system.

  1999cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper

• MRI-based insights into brain structural and functional alterations in schizophrenia treated with risperidone

  2025cites this paper
• Nutrition and schizophrenia: associations worthy of continued revaluation

  2023cites this paper
• Multimodal magnetic resonance neuroimaging measures characteristic of early cART‐treated pediatric HIV: A feature selection approach

  2022cites this paper
• Associations between BMI and brain structures involved in food intake regulation in first-episode schizophrenia spectrum disorders and healthy controls.

  2022cites this paper
• Antipsychotic Medication in Sub-Saharan Africa

  2020cites this paper
• Hippocampal subfield volumes and change in body mass over 12 months of treatment in first-episode schizophrenia spectrum disorders.

  2020cites this paper
• Impaired hormonal regulation of appetite in schizophrenia: A narrative review dissecting intrinsic mechanisms and the effects of antipsychotics.

  2020cites this paper
• Exploring Patterns of Disturbed Eating in Psychosis: A Scoping Review

  2020influential citation
• Alterations in body mass index and waist-to-hip ratio in never and minimally treated patients with psychosis: A systematic review and meta-analysis.

  2019cites this paper
• Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis.

  2019cites this paper
• Role of food‑drug interactions in neurological and psychological diseases.

  2018cites this paper
• Heterogeneity and Homogeneity of Regional Brain Structure in Schizophrenia: A Meta-analysis

  2017cites this paper
• Brain volume changes over the first year of treatment in schizophrenia: relationships to antipsychotic treatment

  2017cites this paper
• Chapter 5 - Antipsychotic Drugs

  2016cites this paper